Leaderboard

En | De
No articles selected!     View Cart  
You are here: Neurology » Multiple Sclerosis 09. April 2026
Search
medline.ch
Multiple Sclerosis
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Alzheimer
Epilepsy
Infections
Headache
Multiple Sclerosis
Neoplasms
Neuromuscular Diseases
Parkinson
Cerebrovascular Diseases
CNS Trauma
Others
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 2186  Previews Next
   
   Articles 1 - 20 / 43711  
   
Iron accumulation in the corpus callosum: a quantitative MRI study in relapsing-remitting multiple sclerosis.
Ir J Med Sci
Al-Radaideh A, Almuqbel MM, Abousrafa S, Radaideh A, Hbahbih M.
PMID: 41951920 [PubMed - as supplied by publisher]


The effects of probiotics supplementation on serum markers of oxidative stress in relapsing-remitting multiple sclerosis: a randomised, double-blind, placebo-controlled clinical trial.
Benef Microbes
Mohy N, Sanaie S, Rahnemayan S, Yousefi M, Talebi M, Naseri A.
PMID: 41951219 [PubMed - as supplied by publisher]


The effect of resistance training on quality of life in people with multiple sclerosis: A systematic review, meta-analysis, and meta-regression.
Am J Med
Ashworth H, Sanal-Hayes NE, Sculthorpe NF, Hendrickse PW, Gaffney CJ, Chan AM, Hayes LD.
PMID: 41950981 [PubMed - as supplied by publisher]


An autoantibody signature predictive for multiple sclerosis: evidence at the protein level and association with histopathological lesion types.
J Neurol
Jarius S, Ruprecht K, Metz I, König FB, Haas J, Brück W, Paul F, Wildemann B.
PMID: 41949651 [PubMed - indexed for MEDLINE]


HERV-W association with serum biomarkers NfL and GFAP in multiple sclerosis.
Front Immunol
Ruberto S, Dominguez-Mozo MI, Villar LM, Costa-Frossard L, Villarrubia N, Aladro Y, Casanova-Peño I, González-Suárez I, Garcia-Martinez MA, Arroyo R, Alvarez-Lafuente R.
PMID: 41948318 [PubMed - indexed for MEDLINE]


Use of complementary therapies is associated with expectations of treatment effectiveness among persons with multiple sclerosis.
BMJ Neurol Open
Staniki, Steinemann N, López-Alcalde J, Canella C, Barth J, Chan A, Roth P, Calabrese P, Zecca C, Gobbi C, Manjaly ZM, Ammann S, Kägi S, Baum C, Kamm CP, Puhan MA, Witt CM, von Wyl V, Swiss Multiple Sclerosis Registry.
PMID: 41948090 [PubMed]


Adjunctive strategies in multiple sclerosis treatment: non-pharmacological approaches and their potential clinical implications.
J Transl Med
Wang Y, Yan W, Yao L, Liu W, Yin Z, Xiao L, Niu J.
PMID: 41947223 [PubMed - as supplied by publisher]


Salivary cortisol as a neuroendocrine stress biomarker for xerostomia in multiple sclerosis patients: a comparative cross-sectional study.
BMC Oral Health
Khabazian T, Khabazian A, Saleh MHA, Samavatijame F, Mohammadi S, Koopaie M.
PMID: 41947123 [PubMed - as supplied by publisher]


Failed, Inconclusive or Interrupted Trials in Multiple Sclerosis: 2020-2024 Update.
Mult Scler Relat Disord
Ricigliano VA, Szejko N, Camera V, Gomez-Figueroa E, Selmaj KW, Samadzadeh S.
PMID: 41946089 [PubMed - as supplied by publisher]


Verbal fluency in multiple sclerosis and neuromyelitis optica spectrum disorders: a systematic review and meta-analysis.
J Clin Exp Neuropsychol
Grigoriadis P, Bakirtzis C, Defteraios S, Lallas K, Goulis DG, Tsimpiris A, Tseriotis VS, Anagnostis P, Messinis L.
PMID: 41944779 [PubMed - as supplied by publisher]


A plain language summary on clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS study.
Neurodegener Dis Manag
Schmierer K, Wiendl H, Barkhof F, Montalban X, Achiron A, Derfuss T, Chan A, Hodgkinson S, Prat A, Leocani L, Sellebjerg F, Vermersch P, Jin H, Sponton L, Chudecka A, Bucello M, Gardner L, De Stefano N.
PMID: 41943490 [PubMed - as supplied by publisher]


Deep Learning Approaches for Multiple Sclerosis Detection in MRI Images.
Biomed Res Int
El Sidani MM, Younes R, Yaacoub C, Abi Zeid Daou R.
PMID: 41943462 [PubMed - indexed for MEDLINE]


Industry Payments and Prescribing of Brand-Name Multiple Sclerosis Medications in Medicare.
Neurology
Patel AN, Kesselheim AS, Rome BN.
PMID: 41941704 [PubMed - indexed for MEDLINE]


Identifying knowledge gaps in reproductive health management for women with multiple sclerosis and healthcare professionals: a scoping review.
Front Neurol
De Santis C, Bove R, Jacobs D, McDonell J, Nonino F, Rijke N, Saylor D, Viswanathan S, Baldin E.
PMID: 41940302 [PubMed]


Assessment of the impact of outcome definitions on power in multiple sclerosis clinical trials.
Mult Scler J Exp Transl Clin
Li CX, Glanz BI, Baharnoori M, Healy BC.
PMID: 41940181 [PubMed]


Impact of cancer on multiple sclerosis-related healthcare and disease-modifying drug use: A multinational cohort study.
Mult Scler
Pierret C, Androdias G, Lebrun-Frenay C, Vukusic S, Maumy M, Ng HS, Zhu F, Tremlett H, Leray E.
PMID: 41936038 [PubMed - as supplied by publisher]


Contrasting genetic architectures of multiple sclerosis susceptibility and outcome phenotypes.
Rev Neurol (Paris)
Sorella MY, Ding Y, Garcia AM, Ygonia M, Wang L, Jacobs BM, Harroud A.
PMID: 41935914 [PubMed - as supplied by publisher]


The evolutionary origins of multiple sclerosis.
Rev Neurol (Paris)
Barrie W.
PMID: 41935913 [PubMed - as supplied by publisher]


Prevalence and predictive factors of epilepsy in multiple sclerosis: A cross-sectional study from Saudi Arabia.
Mult Scler Relat Disord
Busaeed RB, Makkawi S, Almasaad JM, Banjar O, Altayeb A, Alhuzali A, Attar M, Althagafi M, Alotibi MN, Bakadam T.
PMID: 41935523 [PubMed - as supplied by publisher]


Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.
CNS Drugs
Roos I, Sharmin S, Ozakbas S, Alroughani R, Eichau S, Grand'Maison F, Boz C, Lechner-Scott J, Buzzard K, Prat A, Khoury SJ, Grammond P, van der Walt A, Blanco Y, Foschi M, Soysal A, Barnett M, Prevost J, Terzi M, Gerlach O, Macdonell R, Sa MJ, Spitaleri D, Laureys G, van Pesch V, John N, Cartechini E, Gouider R, Maimone D, Ramo-Tello C, Hodgkinson S, Slee M, McCombe P, Garber J, Sanchez-Menoyo JL, Al-Asmi A, Kermode AG, Lapointe E, Shaygannejad V, Van Wijmeersch B, Willekens B, Castillo-Triviño T, Taylor B, Mathey G, Le Page E, De Seze J, Ruet A, Clavelou P, Berger E, Zephir H, Kwiatkowski A, Pelletier J, Moreau T, Labauge P, Ciron J, Lebrun-Frenay C, Papeix C, Defer G, Laplaud DA, Thouvenot E, Stankoff B, Maillart E, Al-Khedr A, Bourre B, Casez O, Dos Santos A, Camdessanche JP, Hankiewicz K, Wahab A, Cabre P, Heinzlef O, Pottier C, Moulin S, Magy L, Labeyrie C, Doghri I, Vukusic S, Kalincik T, MSBase and OFSEP Study Groups.
PMID: 41935174 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 43711    Page 1 of 2186  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1